Cargando…

MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy

Aim: Neoadjuvant chemotherapy may represent a shift in the treatment of locally advanced colon cancer. The angiogenic couple has-microRNA-126 (miRNA-126) and epidermal growth factor-like domain 7 (EGFL7) are transcribed from the same gene and regulates all aspects of angiogenesis and may influence t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Torben Frøstrup, Carlsen, Anting Liu, Tanassi, Julia Tanas, Larsen, Ole, Sørensen, Flemming Brandt, Jensen, Lars Henrik, Jakobsen, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992522/ https://www.ncbi.nlm.nih.gov/pubmed/35582589 http://dx.doi.org/10.20517/cdr.2019.08

Ejemplares similares

Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study
por: Hansen, Torben Frøstrup, et al.
Publicado: (2015)

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer
por: Hansen, Torben Frøstrup, et al.
Publicado: (2012)

The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort
por: Hansen, Torben Frøstrup, et al.
Publicado: (2014)

Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab
por: Hansen, Torben Frøstrup, et al.
Publicado: (2017)

Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts
por: Hansen, Torben Frøstrup, et al.
Publicado: (2018)

Association between the expression of microRNAs and the response of patients with locally advanced rectal cancer to preoperative chemoradiotherapy
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2017)

MicroRNA-200b is downregulated in colon cancer budding cells
por: Knudsen, Kirsten Nguyen, et al.
Publicado: (2017)

MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2016)

microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution
por: Knudsen, Kirsten Nguyen, et al.
Publicado: (2015)

miR-21 expression analysis in budding colon cancer cells by confocal slide scanning microscopy
por: Knudsen, Kirsten Nguyen, et al.
Publicado: (2018)

Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2016)

Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
por: Hansen, T F, et al.
Publicado: (2015)

The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal
por: Dizdarevic, Edina, et al.
Publicado: (2022)

Cell Free Methylated Tumor DNA in Bronchial Lavage as an Additional Tool for Diagnosing Lung Cancer—A Systematic Review
por: Wen, Sara Witting Christensen, et al.
Publicado: (2022)

Re‐exposure to immunotherapy in metastatic colon cancer: A case report
por: Hamre, Tonje Riise, et al.
Publicado: (2021)

Pseudoprogression during treatment with pembrolizumab followed by rechallenge with chemotherapy in metastatic colorectal cancer: A case report
por: Trabjerg, Natacha Dencker, et al.
Publicado: (2019)

The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer
por: Wen, Sara Witting Christensen, et al.
Publicado: (2021)

Analysis of a gene panel for targeted sequencing of colorectal cancer samples
por: Jensen, Klaus Højgaard, et al.
Publicado: (2018)

MicroRNA-126 and epidermal growth factor-like domain 7–an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial
por: Hansen, T F, et al.
Publicado: (2013)

NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
por: Wen, Sara Witting Christensen, et al.
Publicado: (2023)

Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer
por: Wen, Sara W. C., et al.
Publicado: (2021)

Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations
por: Zedan, Ahmed Hussein, et al.
Publicado: (2017)

Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients
por: Borg, Morten, et al.
Publicado: (2022)

Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer()
por: Hansen, Torben Frøstrup, et al.
Publicado: (2019)

NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer
por: Jensen, Lars Henrik, et al.
Publicado: (2019)

Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020)

The Impact of Patient Characteristics and Tumor Biology on the Accuracy of Preoperative Staging of Colon Cancer in Denmark. A Nationwide Cohort Study
por: Pedersen, Malene Roland V., et al.
Publicado: (2021)

The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study()
por: Eriksen, Ann C., et al.
Publicado: (2018)

NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer
por: Raunkilde, Louise, et al.
Publicado: (2022)

Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort
por: Eriksen, Ann C., et al.
Publicado: (2019)

The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
por: Eriksen, Ann Christina, et al.
Publicado: (2018)

Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data
por: Hansen, Torben Frøstrup, et al.
Publicado: (2021)

Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer
por: Carvalho, Robson Francisco, et al.
Publicado: (2021)

CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study
por: Rafaelsen, Søren R., et al.
Publicado: (2022)

Cost-effectiveness of chiropractic care versus self-management in patients with musculoskeletal chest pain
por: Stochkendahl, Mette Jensen, et al.
Publicado: (2016)

At S126
por: CERN PhotoLab
Publicado: (1974)

At S126
por: CERN PhotoLab
Publicado: (1974)

Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis
por: Borg, Morten, et al.
Publicado: (2023)

Local staging of sigmoid colon cancer using MRI
por: Dam, Claus, et al.
Publicado: (2017)

The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer
por: Body, Amy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c6r0tknpa8sucqjd0v424i49ua